BTSG vs CHE stock comparison
BrightSpring Health Services vs. Chemed · data as of November 13, 2026
BrightSpring Health Services (BTSG) has a market value of about $14.2B, Chemed (CHE) about $7.1B. Over their latest twelve months BrightSpring Health Services had revenue of $15.3B and Chemed $2.7B.
On our five checks Chemed scores higher: 2.4 out of 5 (weak) against 1.2 (weak).
By area, the stronger company is BrightSpring Health Services on future growth; Chemed on track record; Chemed on financial health; Chemed on shareholder returns.
Chemed is cheaper on earnings (P/E 26.3 vs. 50.5).
BrightSpring Health Services leads on 6 of the compared lines and Chemed on 15.
Side by side
| BTSG | CHE | |
|---|---|---|
| Size and price | ||
| Market cap | $14.2B | $7.1B |
| Share price | $71.21 | $548.20 |
| Score | ||
| Overall score (of 5) | 1.2 | 2.4 |
| Value | 0 | 0 |
| Future growth | 4 | 0 |
| Track record | 0 | 3 |
| Financial health | 1 | 5 |
| Shareholder returns | 1 | 4 |
| Valuation | ||
| P/E (TTM) | 50.5 | 26.3 |
| Forward P/E | 31.2 | 20.0 |
| Price / free cash flow | 28.8 | 24.1 |
| Price / sales | 0.9 | 2.7 |
| EV / EBITDA | 23.3 | 17.1 |
| PEG | — | — |
| DCF value vs. price | −9% | −7% |
| Business | ||
| Revenue | $15.3B | $2.7B |
| Net income | $410M | $282M |
| Free cash flow | $492M | $295M |
| Net margin | 2.7% | 10.6% |
| Gross margin (5-yr avg.) | 14.2% | 35.0% |
| ROIC (5-yr avg.) | 6.9% | 23.7% |
| Growth | ||
| Revenue growth (1 yr) | 28.2% | 4.1% |
| Revenue growth (5 yrs, per year) | — | 4.0% |
| EPS growth (5 yrs, per year) | — | -1.2% |
| Balance sheet and payouts | ||
| Net cash (cash minus debt) | -$1.6B | -$344M |
| Dividend yield | None | 0.51% |
| Shareholder yield | 0.3% | 6.6% |
| Analysts | ||
| Upside to average target | +17% | +13% |
| Consensus rating | Strong buy | Buy |
Highlighted = the better figure on that line. Revenue, net income and free cash flow: BTSG TTM to September 30, 2026, CHE TTM to September 30, 2026. Not investment advice.
Frequently asked questions
Which is the better stock, BrightSpring Health Services or Chemed?
We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Chemed scores 2.4 out of 5 and BrightSpring Health Services 1.2; the table shows where each one is stronger.
Is BrightSpring Health Services cheaper than Chemed?
On trailing earnings, Chemed trades at a P/E of 26.3 and BrightSpring Health Services at 50.5, so Chemed is cheaper by this measure. A lower P/E can also reflect slower expected growth.
Which pays a higher dividend?
BrightSpring Health Services yields nothing (no dividend) and Chemed 0.51%.
Full BrightSpring Health Services analysis → Full Chemed analysis →
More comparisons
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.